-
Just-published papers in the Journal of the American Medical Association add to heightened concern regarding hormone therapy (HT).
-
Findings from a new Australian study indicate that use of modern, low-dose oral contraceptives (OCs) containing 50 mcg estrogen or less do not appear to appreciably raise the risk of ischemic stroke in healthy women.
-
The word is getting out about emergency contraception (EC). A just-released national survey reports that two-thirds of women ages 18-44 are aware that there is something a woman can do to prevent pregnancy in the few days following sexual intercourse.
-
If you have any patients who use 28-day packages of Nortrel 7/7/7 oral contraceptives (OCs), be sure your clinic has initiated its patient notification plan following the July 9, 2003, voluntary recall issued by the pills manufacturer, Barr Laboratories of Pomona, NY.
-
Black Cohosh May Not Be Safe for Women with Breast Cancer; Viga and Viga for Women Tablets Recalled; Herbal Product Label May Not Accurately Reflect Contents
-
Keegan L. Chaste tree berry for premenstrual syndrome. Altern Ther Women's Health 2003;5(8):57-61.
-
Hardy ML. Tai chi: Benefits in older women. Altern Ther Women's Health 2003;5(8):61-62.
-
The FDA has approved the first nasally administered flu vaccine to be marketed in this country. Medimmunes FluMist is also the first influenza vaccine to use live virus.
-
Following radiation therapy, adjuvant extrafascial hysterectomy decreased the risk of relapse for patients with bulky stage IB cervical cancer without improving survival.
-
Since the introduction of the 3-weekly CHOP (cyclophosphamide, adriamycin, vincristine, prednisone) chemotherapy 25 years ago, many efforts have been undertaken to improve the efficacy of multicycle polychemotherapy for patients with aggressive lymphoma.